Coles N Anthony's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Aug 19, 2021
- Accession no.
- 0001708138-21-000061
- Filed
- Aug 19, 2021
- Trade date
- Aug 17-18, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.90M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coles N AnthonyCIK 0001197018 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | Common Stock | MOption exerciseAcquired | +900 | $345.47 | +$310,923 | 1,802 | Direct | |
| Aug 17, 2021 | Common Stock | SSaleDisposed | −900 | $650.00 | −$585,000 | 902 | Direct | |
| Aug 18, 2021 | Common Stock | MOption exerciseAcquired | +5,100 | $345.47 | +$1,761,897 | 6,002 | Direct | |
| Aug 18, 2021 | Common Stock | SSaleDisposed | −5,100 | $650.00 | −$3,315,000 | 902 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | Common Stock | MOption exerciseDisposed | −900 | $0.00 | $0 | 10,139 | Direct | |
| Aug 18, 2021 | Common Stock | MOption exerciseDisposed | −5,100 | $0.00 | $0 | 5,039 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.